Herzinsuffizienz (allg.)

Aus PlusPedia
Wechseln zu: Navigation, Suche
Entstehender Artikel
Siehe auch
Freie Übersichtsartikel [1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43][44][45][46][47][48][49][50][51][52][53][54][55][56][57][58][59][60][61][62][63][64][65][66][67][68][69][70][71][72][73][74][75][76][77][78][79][80][81][82][83][84][85][86][87][88][89][90][91][92][93][94][95][96][97][98][99][100][101][102][103][104][105][106][107][108][109][110][111][112][113][114][115][116][117][118][119][120][121][122][123][124][125][126][127]
Wichtige Übersichtsartikel
Medline Suchterm/ Synonyme
Was ist das
Struktur
Physiologie
Knockout
Transgen
Mutation
Polymorphismus
Genexpression
Inhibitoren
Agonisten

1 Bibliographie

  1. ↑ Beta blockers as cardioprotective agents: Part II--Focus on prevention of sudden cardiac death. Am J Manag Care 8(9 Suppl):18-24 (2002) PMID 12099324
  2. ↑ Beta blockers as cardioprotective agents: Part I--Insights into mechanisms of action. Am J Manag Care 8(9 Suppl):13-7 (2002) PMID 12099323
  3. ↑ Disease management of congestive heart failure. Am J Manag Care 5(4):499-507; quiz 508-9 (1999) PMID 10387388
  4. ↑ Clinical practice guidelines for heart failure. Am J Manag Care 4(6 Suppl):S329-37 (1998) PMID 10184925
  5. ↑ Cardiac resynchronization therapy and adrenergic mechanisms. Am J Physiol Heart Circ Physiol 291(6):H2590-1 (2006) PMID 16877559
  6. ↑ Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure. Ann Intern Med 150(11):784-94 (2009) PMID 19487713
  7. ↑ In the Clinic. Heart failure. Ann Intern Med 147(11):ITC12-1-ITC12-16 (2007) PMID 18056658
  8. ↑ Narrative review: pharmacotherapy for chronic heart failure: evidence from recent clinical trials. Ann Intern Med 142(2):132-45 (2005) PMID 15657162
  9. ↑ Beta-blockers in congestive heart failure. A Bayesian meta-analysis. Ann Intern Med 134(7):550-60 (2001) PMID 11281737
  10. ↑ Myocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesis. Arthritis Res Ther 7(5):195-207 (2005) PMID 16207349
  11. ↑ Non-invasive methods for the assessment of cardiac function. Calif Med 119(3):21-37 (1973) PMID 4270111
  12. ↑ The pulmonary manifestations of left heart failure. Chest 125(2):669-82 (2004) PMID 14769751
  13. ↑ Alveolar-capillary membrane dysfunction in heart failure: evidence of a pathophysiologic role. Chest 124(3):1090-102 (2003) PMID 12970042
  14. ↑ A review of why and how we may use beta-blockers in congestive heart failure. Chest 113(3):800-8 (1998) PMID 9515860
  15. ↑ Prevalence of congestion in chronic heart failure. Chest 90(3):311-2 (1986) PMID 3743140
  16. ↑ Loop diuretics in acute decompensated heart failure: necessary? Evil? A necessary evil? Circ Heart Fail 2(1):56-62 (2009) PMID 19750134
  17. ↑ What is the role of beta-adrenergic signaling in heart failure? Circ Res 93(10):896-906 (2003) PMID 14615493
  18. ↑ Parasympathetic nervous system and heart failure: pathophysiology and potential implications for therapy. Circulation 118(8):863-71 (2008) PMID 18711023
  19. ↑ Contemporary trends in the pharmacological and extracorporeal management of heart failure: a nephrologic perspective. Circulation 117(7):975-83 (2008) PMID 18285578
  20. ↑ New-onset heart failure in children in the absence of structural congenital heart disease. Circulation 117(1):11-2 (2008) PMID 18172048
  21. ↑ National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine practice guidelines: Analytical issues for biomarkers of heart failure. Circulation 116(5):e95-8 (2007) PMID 17630411
  22. ↑ National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: Clinical utilization of cardiac biomarker testing in heart failure. Circulation 116(5):e99-109 (2007) PMID 17630410
  23. ↑ Metabolic mechanisms in heart failure. Circulation 116(4):434-48 (2007) PMID 17646594
  24. ↑ Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction. Circulation 113(24):2851-60 (2006) PMID 16785351
  25. ↑ Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation 113(19):2335-62 (2006) PMID 16702488
  26. ↑ ACC/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with chronic heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Heart Failure Clinical Data Standards): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Failure Society of America. Circulation 112(12):1888-916 (2005) PMID 16162914
  27. ↑ ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 112(12):e154-235 (2005) PMID 16160202
  28. ↑ ACC/AHA Clinical Performance Measures for Adults with Chronic Heart Failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures): endorsed by the Heart Failure Society of America. Circulation 112(12):1853-87 (2005) PMID 16160201
  29. ↑ Mechanical device-based methods of managing and treating heart failure. Circulation 112(3):438-48 (2005) PMID 16027272
  30. ↑ Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation 111(21):2837-49 (2005) PMID 15927992
  31. ↑ Cardiac resynchronization therapy for heart failure. Circulation 108(21):2596-603 (2003) PMID 14638522
  32. ↑ How do beta-blockers improve ventricular function in patients with congestive heart failure? Circulation 107(19):2395-7 (2003) PMID 12756189
  33. ↑ Antiadrenergic therapy of chronic heart failure: surprises and new opportunities. Circulation 107(8):1100-2 (2003) PMID 12615784
  34. ↑ Sympathetic nervous system in heart failure. Circulation 106(19):2417-8 (2002) PMID 12417535
  35. ↑ Contemporary medical options for treating patients with heart failure. Circulation 105(19):2244-6 (2002) PMID 12010904
  36. ↑ New therapeutic options in congestive heart failure: Part II. Circulation 105(18):2223-8 (2002) PMID 11994259
  37. ↑ New therapeutic options in congestive heart failure: Part I. Circulation 105(17):2099-106 (2002) PMID 11980691
  38. ↑ The "unsympathetic" nervous system of heart failure. Circulation 105(15):1753-5 (2002) PMID 11956112
  39. ↑ ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America. Circulation 104(24):2996-3007 (2001) PMID 11739319
  40. ↑ Catecholamines, cardiac beta-adrenergic receptors, and heart failure. Circulation 101(14):1634-7 (2000) PMID 10758041
  41. ↑ beta-adrenergic receptor blockade in chronic heart failure. Circulation 101(5):558-69 (2000) PMID 10662755
  42. ↑ Mechanisms and models in heart failure: A combinatorial approach. Circulation 100(9):999-1008 (1999) PMID 10468532
  43. ↑ Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials. Circulation 98(12):1184-91 (1998) PMID 9743509
  44. ↑ Evolving concepts of left ventricular hypertrophy. Eur Heart J 29(7):846-8 (2008) PMID 18337237
  45. ↑ Heart failure with preserved ejection fraction: dangerous, elusive, and difficult. Eur Heart J 29(3):285-7 (2008) PMID 18202254
  46. ↑ Heart failure therapy: testosterone replacement and its implications. Eur Heart J 27(1):10-2 (2006) PMID 16291772
  47. ↑ The importance of the gastrointestinal system in the pathogenesis of heart failure. Eur Heart J 26(22):2368-74 (2005) PMID 15980032
  48. ↑ Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26(11):1115-40 (2005) PMID 15901669
  49. ↑ Expert consensus document on beta-adrenergic receptor blockers. Eur Heart J 25(15):1341-62 (2004) PMID 15288162
  50. ↑ Refractory heart failure - drugs and devices. Eur Heart J 22(24):2227-30 (2001) PMID 11728141
  51. ↑ The 6-minute walk. A simple test with clinical application. Eur Heart J 21(7):507-8 (2000) PMID 10775001
  52. ↑ Beta-blockers continue to surprise us. Eur Heart J 21(5):354-64 (2000) PMID 10666349
  53. ↑ Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry. Eur Heart J 20(16):1182-90 (1999) PMID 10448027
  54. ↑ The treatment of heart failure. Task Force of the Working Group on Heart Failure of the European Society of Cardiology. Eur Heart J 18(5):736-53 (1997) PMID 9152644
  55. ↑ Effects of beta-blocker therapy on mortality in patients with heart failure. A systematic overview of randomized controlled trials. Eur Heart J 18(4):560-5 (1997) PMID 9129883
  56. ↑ Beta-blocking agents in heart failure. Should they be used and how? Eur Heart J 17(11):1629-39 (1996) PMID 8922910
  57. ↑ Congestive heart failure. Towards a comprehensive treatment. Eur Heart J 17 Suppl B():43-56 (1996) PMID 8733071
  58. ↑ Beta-blockers in heart failure. Future directions. Eur Heart J 17 Suppl B():39-42 (1996) PMID 8733070
  59. ↑ Carvedilol, a novel vasodilating beta-blocker with the potential for cardiovascular organ protection. Eur Heart J 17 Suppl B():24-9 (1996) PMID 8733068
  60. ↑ Beta-blockade in the management of chronic heart failure. Another step in the conceptual evolution of a neurohormonal model of the disease. Eur Heart J 17 Suppl B():21-3 (1996) PMID 8733067
  61. ↑ Beta-blockers in heart failure--the evidence from clinical trials. Eur Heart J 17 Suppl B():17-20 (1996) PMID 8733066
  62. ↑ Cardiac adrenergic receptor effects of carvedilol. Eur Heart J 17 Suppl B():8-16 (1996) PMID 8733065
  63. ↑ Angiotensin blockade or aldosterone blockade as the third neuroendocrine-blocking drug in mild but symptomatic heart failure patients. Heart 92(12):1728-31 (2006) PMID 16339814
  64. ↑ Systematic review of multidisciplinary interventions in heart failure. Heart 91(7):899-906 (2005) PMID 15958358
  65. ↑ Heart failure: aetiology, diagnosis, and treatment. Heart 88(6):567-9 (2002) PMID 12433879
  66. ↑ Heart failure: What causes the symptoms of heart failure? Heart 86(5):574-8 (2001) PMID 11602559
  67. ↑ Heart Failure: Treatment strategies for heart failure: beta blockers andantiarrhythmics. Heart 85(1):97-103 (2001) PMID 11119476
  68. ↑ Non-transplant surgery for heart failure. Heart 83(5):603-10 (2000) PMID 10768919
  69. ↑ Epidemiology, aetiology, and prognosis of heart failure. Heart 83(5):596-602 (2000) PMID 10768918
  70. ↑ Major beta blocker mortality trials in chronic heart failure: a critical review. Heart 82 Suppl 4():IV14-22 (1999) PMID 10574906
  71. ↑ The origin of symptoms in chronic heart failure. Heart 78(5):429-30 (1997) PMID 9414998
  72. ↑ Novel mechanisms of sympathetic regulation in chronic heart failure. Hypertension 48(6):1005-11 (2006) PMID 17015773
  73. ↑ Adherence to guidelines improves the clinical outcome of patients with acutely decompensated heart failure. Isr Med Assoc J 11(6):348-53 (2009) PMID 19697585
  74. ↑ Heart failure--new insights. Isr Med Assoc J 11(2):105-11 (2009) PMID 19432040
  75. ↑ Cardiac resynchronization therapy for heart failure shows great promise. Isr Med Assoc J 5(8):589-91 (2003) PMID 12929300
  76. ↑ Anemia and mortality in heart failure patients a systematic review and meta-analysis. J Am Coll Cardiol 52(10):818-27 (2008) PMID 18755344
  77. ↑ Anemia and chronic heart failure implications and treatment options. J Am Coll Cardiol 52(7):501-11 (2008) PMID 18687241
  78. ↑ Vasodilator therapy for decompensated heart failure. J Am Coll Cardiol 52(3):208-10 (2008) PMID 18617069
  79. ↑ Cardiac effects of growth hormone treatment in chronic heart failure: A meta-analysis. J Clin Endocrinol Metab 92(1):180-5 (2007) PMID 17062772
  80. ↑ Altered intracellular Ca2+ handling in heart failure. J Clin Invest 115(3):556-64 (2005) PMID 15765137
  81. ↑ Mitochondrial energy metabolism in heart failure: a question of balance. J Clin Invest 115(3):547-55 (2005) PMID 15765136
  82. ↑ Genetic causes of human heart failure. J Clin Invest 115(3):518-26 (2005) PMID 15765133
  83. ↑ NO/redox disequilibrium in the failing heart and cardiovascular system. J Clin Invest 115(3):509-17 (2005) PMID 15765132
  84. ↑ Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 115(3):500-8 (2005) PMID 15765131
  85. ↑ Learning from failure: congestive heart failure in the postgenomic age. J Clin Invest 115(3):495-9 (2005) PMID 15765130
  86. ↑ Beta-adrenergic receptors in the failing heart: the good, the bad, and the unknown. J Clin Invest 107(8):947-8 (2001) PMID 11306597
  87. ↑ Beta-adrenergic receptors in heart failure. J Clin Invest 92(6):2564 (1993) PMID 8254011
  88. ↑ BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial. JAMA 301(4):383-92 (2009) PMID 19176440
  89. ↑ beta-Blockers in heart failure: clinical applications. JAMA 287(7):890-7 (2002) PMID 11851583
  90. ↑ beta-Blocker therapy in heart failure: scientific review. JAMA 287(7):883-9 (2002) PMID 11851582
  91. ↑ Medical management of advanced heart failure. JAMA 287(5):628-40 (2002) PMID 11829703
  92. ↑ Arrhythmias and sudden death in heart failure. Jpn Circ J 61(9):727-40 (1997) PMID 9293402
  93. ↑ Therapy of heart failure. Kidney Int 57(4):1418-25 (2000) PMID 10760077
  94. ↑ Aldosterone receptor antagonists in the medical management of chronic heart failure. Mayo Clin Proc 80(12):1623-30 (2005) PMID 16342656
  95. ↑ Beta-blockers in chronic heart failure: considerations for selecting an agent. Mayo Clin Proc 77(11):1199-206 (2002) PMID 12440556
  96. ↑ Beta-blockers: new standard therapy for heart failure. Mayo Clin Proc 77(8):839-45; quiz 845-6 (2002) PMID 12173717
  97. ↑ Use of diuretics in cardiovascular diseases: (1) heart failure. Postgrad Med J 80(942):201-5 (2004) PMID 15082840
  98. ↑ Drug therapy in chronic heart failure. Postgrad Med J 79(937):634-42 (2003) PMID 14654574
  99. ↑ Mechanisms and management of diuretic resistance in congestive heart failure. Postgrad Med J 79(931):268-71 (2003) PMID 12782772
  100. ↑ Recent advances in the drug treatment of heart failure. Postgrad Med J 74(877):658-61 (1998) PMID 10197196
  101. ↑ The management of congestive heart failure. Postgrad Med J 73(858):194-200 (1997) PMID 9156120
  102. ↑ Diagnosis and management of heart failure in the elderly. Postgrad Med J 72(852):577-80 (1996) PMID 8977936
  103. ↑ Heart involvement in systemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupus. Rheumatology (Oxford) 45 Suppl 4():iv8-13 (2006) PMID 16980725
  104. ↑ End-stage chronic heart failure. Swiss Med Wkly 137(7-8):107-13 (2007) PMID 17370148
  105. ↑ Pathophysiology of heart failure: a look at the future. Tex Heart Inst J 26(1):28-33 (1999) PMID 10217468
  106. ↑ Heart failure: Part II. West J Med 170(6):339-42 (1999) PMID 10443162
  107. ↑ Congestive heart failure. New frontiers. West J Med 154(4):427-41 (1991) PMID 1678903
  108. ↑ Managing congestive heart failure medically--what have we learned? West J Med 153(4):442-4 (1990) PMID 2244381
  109. ↑ Medical management of congestive heart failure. West J Med 153(4):406-14 (1990) PMID 2244376
  110. ↑ The challenge of correcting volume overload in hospitalized patients with decompensated heart failure. J Am Coll Cardiol 49(6):684-6 (2007) PMID 17291933
  111. ↑ Emerging therapies for the management of decompensated heart failure: from bench to bedside. J Am Coll Cardiol 48(12):2397-409 (2006) PMID 17174176
  112. ↑ Ultrafiltration: a new approach toward mechanical diuresis in heart failure. J Am Coll Cardiol 46(11):2052-3 (2005) PMID 16325041
  113. ↑ Vasopressin antagonism in heart failure. J Am Coll Cardiol 46(10):1785-91 (2005) PMID 16286160
  114. ↑ Furosemide in the long-term management of heart failure: the good, the bad, and the uncertain. J Am Coll Cardiol 44(6):1308-10 (2004) PMID 15364337
  115. ↑ Anemia as a risk factor and therapeutic target in heart failure. J Am Coll Cardiol 44(5):959-66 (2004) PMID 15337204
  116. ↑ Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. J Am Coll Cardiol 43(3):317-27 (2004) PMID 15013109
  117. ↑ Predicting cardiac resynchronization response by QRS duration: the long and short of it. J Am Coll Cardiol 42(12):2125-7 (2003) PMID 14680738
  118. ↑ Colloid osmotic pressure: an under-recognized factor in the clinical syndrome of heart failure. J Am Coll Cardiol 42(4):717-8 (2003) PMID 12932608
  119. ↑ The regulation and measurement of plasma volume in heart failure. J Am Coll Cardiol 39(12):1901-8 (2002) PMID 12084586
  120. ↑ ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 38(7):2101-13 (2001) PMID 11738322
  121. ↑ Heart failure with preserved systolic function. A different natural history? J Am Coll Cardiol 38(5):1277-82 (2001) PMID 11691495
  122. ↑ The role of tumor necrosis factor in the pathophysiology of heart failure. J Am Coll Cardiol 35(3):537-44 (2000) PMID 10716453
  123. ↑ Drug-induced heart failure. J Am Coll Cardiol 33(5):1152-62 (1999) PMID 10193711
  124. ↑ Etiology and response to drug treatment in heart failure. J Am Coll Cardiol 32(5):1167-72 (1998) PMID 9809921
  125. ↑ Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials. J Am Coll Cardiol 30(1):27-34 (1997) PMID 9207617
  126. ↑ Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure). J Am Coll Cardiol 26(5):1376-98 (1995) PMID 7594057
  127. ↑ Renal and circulatory mechanisms in congestive heart failure. Kidney Int 31(6):1402-15 (1987) PMID 2956452

2 Andere Lexika

Abgerufen von „http://de.pluspedia.org/w/index.php?title=Herzinsuffizienz_(allg.)&oldid=40485“

Diesen Artikel melden!
Verletzt dieser Artikel deine Urheber- oder Persönlichkeitsrechte?
Hast du einen Löschwunsch oder ein anderes Anliegen? Dann nutze bitte unser Kontaktformular

PlusPedia Impressum
Diese Seite mit Freunden teilen:
Mr Wong Digg Delicious Yiggit wikio Twitter
Facebook


Bitte Beachte:
Sämtliche Aussagen auf dieser Seite sind ohne Gewähr.
Für die Richtigkeit der Aussagen übernimmt die Betreiberin keine Verantwortung.
Nach Kenntnissnahme von Fehlern und Rechtsverstößens ist die Betreiberin selbstverständlich bereit,
diese zu beheben.

Verantwortlich für jede einzelne Aussage ist der jeweilige Erstautor dieser Aussage.
Mit dem Ergänzen und Weiterschreiben eines Artikels durch einen anderen Autor
werden die vorhergehenden Aussagen und Inhalte nicht zu eigenen.
Die Weiternutzung und Glaubhaftigkeit der Inhalte ist selbst gegenzurecherchieren.


Typo3 Besucherzähler - Seitwert blog counter
java hosting vpn norway